Citi raised the firm’s price target on GE HealthCare (GEHC) to $110 from $103 and keeps a Buy rating on the shares. Operating margins expanded ...
Sees FY25 organic revenue growth of 2%-3% year-over-year, which reflects continued demand for products and services as well as a measured view ...
GE HealthCare Q4 earnings beat estimates with strong U.S. demand. 2025 outlook includes 2%-3% revenue growth and EPS guidance of $4.61-$4.75.
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) in Q4 CY2024, with sales up 2.2% year on year to $5.32 ...
GE HealthCare Technologies delivered solid fourth-quarter earnings, but domestic and international revenue growth remained ...
GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2024. GE HealthCare President an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results